+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vitreoretinal Surgery Devices Market By Product: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994031
The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Perfluorocarbon Liquids
  • Endoillumination Instrument
  • Vitreoretinal Prefilled Silicone Oil Syringes
  • Vitrectomy System
  • Other

By Surgery Type

  • Anterior Vitreoretinal Surgery
  • Posterior Vitreoretinal Surgery

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Bausch & Lomb
  • Novartis AG
  • Inami & Co
  • Paragon Care Group Pty Ltd
  • Oculus Inc
  • MedOne Surgical, Inc
  • Carl Zeiss Meditec AG
  • Peregrine Surgical
  • Johnson & Johnson
  • Blink Medical

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Perfluorocarbon Liquids
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Endoillumination Instrument
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Vitreoretinal Prefilled Silicone Oil Syringes
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Vitrectomy System
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Other
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Surgery Type
5.2. Anterior Vitreoretinal Surgery
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Posterior Vitreoretinal Surgery
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Specialty Clinics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Ambulatory Surgery Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Surgery Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Vitreoretinal Surgery Devices Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Surgery Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Vitreoretinal Surgery Devices Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Surgery Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Vitreoretinal Surgery Devices Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Surgery Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Surgery Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Vitreoretinal Surgery Devices Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Surgery Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Vitreoretinal Surgery Devices Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Surgery Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Vitreoretinal Surgery Devices Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Surgery Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Vitreoretinal Surgery Devices Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Surgery Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Vitreoretinal Surgery Devices Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Surgery Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Surgery Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Surgery Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Vitreoretinal Surgery Devices Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Surgery Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Vitreoretinal Surgery Devices Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Surgery Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Vitreoretinal Surgery Devices Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Surgery Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Vitreoretinal Surgery Devices Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Surgery Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Vitreoretinal Surgery Devices Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Surgery Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Surgery Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Surgery Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Vitreoretinal Surgery Devices Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Surgery Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Surgery Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Vitreoretinal Surgery Devices Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Surgery Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Surgery Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Bausch And Lomb
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Novartis AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Inami And Co
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Paragon Care Group Pty Ltd
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Oculus Inc
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. MedOne Surgical, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Carl Zeiss Meditec AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Peregrine Surgical
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Johnson And Johnson
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Blink Medical
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 2. Vitreoretinal Surgery Devices Market for Perfluorocarbon Liquids, by Region, 2024 - 2033 ($Billion)
Table 3. Vitreoretinal Surgery Devices Market for Endoillumination Instrument, by Region, 2024 - 2033 ($Billion)
Table 4. Vitreoretinal Surgery Devices Market for Vitreoretinal Prefilled Silicone Oil Syringes, by Region, 2024 - 2033 ($Billion)
Table 5. Vitreoretinal Surgery Devices Market for Vitrectomy System, by Region, 2024 - 2033 ($Billion)
Table 6. Vitreoretinal Surgery Devices Market for Other, by Region, 2024 - 2033 ($Billion)
Table 7. Global Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 8. Vitreoretinal Surgery Devices Market for Anterior Vitreoretinal Surgery, by Region, 2024 - 2033 ($Billion)
Table 9. Vitreoretinal Surgery Devices Market for Posterior Vitreoretinal Surgery, by Region, 2024 - 2033 ($Billion)
Table 10. Global Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 11. Vitreoretinal Surgery Devices Market for Hospitals, by Region, 2024 - 2033 ($Billion)
Table 12. Vitreoretinal Surgery Devices Market for Specialty Clinics, by Region, 2024 - 2033 ($Billion)
Table 13. Vitreoretinal Surgery Devices Market for Ambulatory Surgery Centers, by Region, 2024 - 2033 ($Billion)
Table 14. Vitreoretinal Surgery Devices Market, by Region, 2024 - 2033 ($Billion)
Table 15. North America Vitreoretinal Surgery Devices Market, by Country, 2024 - 2033 ($Billion)
Table 16. North America Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 17. North America Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 18. North America Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 19. U.S. Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 20. U.S. Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 21. U.S. Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 22. Canada Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 23. Canada Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 24. Canada Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Mexico Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 26. Mexico Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 27. Mexico Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 28. Europe Vitreoretinal Surgery Devices Market, by Country, 2024 - 2033 ($Billion)
Table 29. Europe Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 30. Europe Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 31. Europe Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 32. Germany Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 33. Germany Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 34. Germany Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 35. France Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 36. France Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 37. France Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 38. UK Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 39. UK Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 40. UK Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 41. Italy Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 42. Italy Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 43. Italy Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 44. Spain Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 45. Spain Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 46. Spain Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Rest of Europe Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 48. Rest of Europe Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 49. Rest of Europe Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 50. Asia-Pacific Vitreoretinal Surgery Devices Market, by Country, 2024 - 2033 ($Billion)
Table 51. Asia-Pacific Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 52. Asia-Pacific Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 53. Asia-Pacific Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 54. Japan Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 55. Japan Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 56. Japan Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 57. China Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 58. China Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 59. China Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 60. Australia Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 61. Australia Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 62. Australia Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 63. India Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 64. India Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 65. India Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 66. South Korea Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 67. South Korea Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 68. South Korea Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 69. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 70. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 71. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 72. LAMEA Vitreoretinal Surgery Devices Market, by Country, 2024 - 2033 ($Billion)
Table 73. LAMEA Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 74. LAMEA Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 75. LAMEA Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 76. Brazil Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 77. Brazil Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 78. Brazil Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 79. Saudi Arabia Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 80. Saudi Arabia Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 81. Saudi Arabia Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 82. South Africa Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 83. South Africa Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 84. South Africa Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 85. Rest of LAMEA Vitreoretinal Surgery Devices Market, by Product, 2024 - 2033 ($Billion)
Table 86. Rest of LAMEA Vitreoretinal Surgery Devices Market, by Surgery Type, 2024 - 2033 ($Billion)
Table 87. Rest of LAMEA Vitreoretinal Surgery Devices Market, by End-user, 2024 - 2033 ($Billion)
Table 88. Bausch and Lomb: Key Executives
Table 89. Bausch and Lomb: Company Snapshot
Table 90. Bausch and Lomb: Operating Segments
Table 91. Bausch and Lomb: Product Portfolio
Table 92. Bausch and Lomb: Key Strategic Moves and Developments
Table 93. Novartis AG: Key Executives
Table 94. Novartis AG: Company Snapshot
Table 95. Novartis AG: Operating Segments
Table 96. Novartis AG: Product Portfolio
Table 97. Novartis AG: Key Strategic Moves and Developments
Table 98. Inami and Co: Key Executives
Table 99. Inami and Co: Company Snapshot
Table 100. Inami and Co: Operating Segments
Table 101. Inami and Co: Product Portfolio
Table 102. Inami and Co: Key Strategic Moves and Developments
Table 103. Paragon Care Group Pty Ltd.: Key Executives
Table 104. Paragon Care Group Pty Ltd.: Company Snapshot
Table 105. Paragon Care Group Pty Ltd.: Operating Segments
Table 106. Paragon Care Group Pty Ltd.: Product Portfolio
Table 107. Paragon Care Group Pty Ltd.: Key Strategic Moves and Developments
Table 108. Oculus Inc.: Key Executives
Table 109. Oculus Inc.: Company Snapshot
Table 110. Oculus Inc.: Operating Segments
Table 111. Oculus Inc.: Product Portfolio
Table 112. Oculus Inc.: Key Strategic Moves and Developments
Table 113. Medone Surgical, Inc.: Key Executives
Table 114. Medone Surgical, Inc.: Company Snapshot
Table 115. Medone Surgical, Inc.: Operating Segments
Table 116. Medone Surgical, Inc.: Product Portfolio
Table 117. Medone Surgical, Inc.: Key Strategic Moves and Developments
Table 118. Carl Zeiss Meditec AG: Key Executives
Table 119. Carl Zeiss Meditec AG: Company Snapshot
Table 120. Carl Zeiss Meditec AG: Operating Segments
Table 121. Carl Zeiss Meditec AG: Product Portfolio
Table 122. Carl Zeiss Meditec AG: Key Strategic Moves and Developments
Table 123. Peregrine Surgical: Key Executives
Table 124. Peregrine Surgical: Company Snapshot
Table 125. Peregrine Surgical: Operating Segments
Table 126. Peregrine Surgical: Product Portfolio
Table 127. Peregrine Surgical: Key Strategic Moves and Developments
Table 128. Johnson and Johnson: Key Executives
Table 129. Johnson and Johnson: Company Snapshot
Table 130. Johnson and Johnson: Operating Segments
Table 131. Johnson and Johnson: Product Portfolio
Table 132. Johnson and Johnson: Key Strategic Moves and Developments
Table 133. Blink Medical: Key Executives
Table 134. Blink Medical: Company Snapshot
Table 135. Blink Medical: Operating Segments
Table 136. Blink Medical: Product Portfolio
Table 137. Blink Medical: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Vitreoretinal Surgery Devices Market, 2024 - 2033
Figure 2. Segmentation of Vitreoretinal Surgery Devices Market, 2024 - 2033
Figure 3. Top Investment Pocket in Vitreoretinal Surgery Devices Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalvitreoretinal Surgery Devices Market
Figure 10. Global Vitreoretinal Surgery Devices Market Segmentation, by Product
Figure 11. Vitreoretinal Surgery Devices Market for Perfluorocarbon Liquids, by Country, 2024 - 2033 ($Billion)
Figure 12. Vitreoretinal Surgery Devices Market for Endoillumination Instrument, by Country, 2024 - 2033 ($Billion)
Figure 13. Vitreoretinal Surgery Devices Market for Vitreoretinal Prefilled Silicone Oil Syringes, by Country, 2024 - 2033 ($Billion)
Figure 14. Vitreoretinal Surgery Devices Market for Vitrectomy System, by Country, 2024 - 2033 ($Billion)
Figure 15. Vitreoretinal Surgery Devices Market for Other, by Country, 2024 - 2033 ($Billion)
Figure 16. Global Vitreoretinal Surgery Devices Market Segmentation, by Surgery Type
Figure 17. Vitreoretinal Surgery Devices Market for Anterior Vitreoretinal Surgery, by Country, 2024 - 2033 ($Billion)
Figure 18. Vitreoretinal Surgery Devices Market for Posterior Vitreoretinal Surgery, by Country, 2024 - 2033 ($Billion)
Figure 19. Global Vitreoretinal Surgery Devices Market Segmentation, by End-user
Figure 20. Vitreoretinal Surgery Devices Market for Hospitals, by Country, 2024 - 2033 ($Billion)
Figure 21. Vitreoretinal Surgery Devices Market for Specialty Clinics, by Country, 2024 - 2033 ($Billion)
Figure 22. Vitreoretinal Surgery Devices Market for Ambulatory Surgery Centers, by Country, 2024 - 2033 ($Billion)
Figure 23. Top Winning Strategies, by Year, 2021-2023*
Figure 24. Top Winning Strategies, by Development, 2021-2023*
Figure 25. Top Winning Strategies, by Company, 2021-2023*
Figure 26. Product Mapping of Top 10 Players
Figure 27. Competitive Dashboard
Figure 28. Competitive Heatmap: Vitreoretinal Surgery Devices Market
Figure 29. Top Player Positioning, 2023
Figure 30. Bausch and Lomb: Net Sales, 2021-2023 ($Billion)
Figure 31. Bausch and Lomb: Revenue Share, by Segment, 2023 (%)
Figure 32. Bausch and Lomb: Revenue Share, by Region, 2023 (%)
Figure 33. Novartis AG: Net Sales, 2021-2023 ($Billion)
Figure 34. Novartis AG: Revenue Share, by Segment, 2023 (%)
Figure 35. Novartis AG: Revenue Share, by Region, 2023 (%)
Figure 36. Inami and Co: Net Sales, 2021-2023 ($Billion)
Figure 37. Inami and Co: Revenue Share, by Segment, 2023 (%)
Figure 38. Inami and Co: Revenue Share, by Region, 2023 (%)
Figure 39. Paragon Care Group Pty Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 40. Paragon Care Group Pty Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 41. Paragon Care Group Pty Ltd.: Revenue Share, by Region, 2023 (%)
Figure 42. Oculus Inc.: Net Sales, 2021-2023 ($Billion)
Figure 43. Oculus Inc.: Revenue Share, by Segment, 2023 (%)
Figure 44. Oculus Inc.: Revenue Share, by Region, 2023 (%)
Figure 45. Medone Surgical, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 46. Medone Surgical, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 47. Medone Surgical, Inc.: Revenue Share, by Region, 2023 (%)
Figure 48. Carl Zeiss Meditec AG: Net Sales, 2021-2023 ($Billion)
Figure 49. Carl Zeiss Meditec AG: Revenue Share, by Segment, 2023 (%)
Figure 50. Carl Zeiss Meditec AG: Revenue Share, by Region, 2023 (%)
Figure 51. Peregrine Surgical: Net Sales, 2021-2023 ($Billion)
Figure 52. Peregrine Surgical: Revenue Share, by Segment, 2023 (%)
Figure 53. Peregrine Surgical: Revenue Share, by Region, 2023 (%)
Figure 54. Johnson and Johnson: Net Sales, 2021-2023 ($Billion)
Figure 55. Johnson and Johnson: Revenue Share, by Segment, 2023 (%)
Figure 56. Johnson and Johnson: Revenue Share, by Region, 2023 (%)
Figure 57. Blink Medical: Net Sales, 2021-2023 ($Billion)
Figure 58. Blink Medical: Revenue Share, by Segment, 2023 (%)
Figure 59. Blink Medical: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Vitreoretinal Surgery Devices Market include:
  • Bausch & Lomb
  • Novartis AG
  • Inami & Co
  • Paragon Care Group Pty Ltd
  • Oculus Inc
  • MedOne Surgical, Inc
  • Carl Zeiss Meditec AG
  • Peregrine Surgical
  • Johnson & Johnson
  • Blink Medical

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information